SerenQ Retatrutide Pen
Price range: £140.00 through £210.00 & Free Shipping
20mg / 40mg
300 units
66.7mcg / 133mcg
Pre-filled pen
FREE SHIPPING
On orders over £200
✓
UK Fast Dispatch
Research Grade
Description
Retatrutide Pre-Filled Peptide Pen
SerenQ Retatrutide is a synthetic investigational peptide supplied in a sealed,
pre-filled pen format. Available in 20mg and 40mg strengths,
both variants use the same 3ml, 300-unit pen platform, with the
concentration varying between strengths.
The pre-filled format eliminates the need to reconstitute a lyophilised product
before laboratory handling. Each pen is supplied in a sealed retail carton with
product identification, batch information, serialisation and QR verification.
Two strengths · One pen format
20mg Retatrutide
20mg total peptide content in a 3ml pre-filled pen with a graduated
300-unit scale.
40mg Retatrutide
40mg total peptide content in a 3ml pre-filled pen with the same
graduated 300-unit format.
Pre-Filled Format
Supplied as a ready-filled pen rather than a conventional lyophilised
vial requiring separate reconstitution.
Serialised Identification
Each product carries a unique serial number and QR code for product
authentication and batch information.
Retatrutide 20mg
Retatrutide 40mg
Concentration & Pen Format
Both variants contain retatrutide in a 3ml pre-filled pen with a
300-unit graduated scale. The two strengths differ only in the total
peptide concentration.
The stated concentration is derived from the supplied total peptide
content divided by the stated 3ml fill volume. The graduated pen scale
provides volume markings for laboratory research handling.
What is Retatrutide?
Retatrutide is a synthetic investigational peptide designed to interact with
three receptor pathways: the GLP-1 receptor, GIP receptor and glucagon
receptor. This combination distinguishes retatrutide from single- and
dual-receptor agonists.
The compound has been investigated in clinical research relating to metabolic
pathways, body weight, adiposity, glucose regulation, appetite signalling and
energy metabolism. Its triple-receptor mechanism has made it an important
subject of ongoing peptide research.
Retatrutide remains an investigational compound and should not be represented
as an approved medicinal product or as an established treatment.
Three receptor pathways
GLP-1
A receptor pathway involved in glucose-dependent insulin signalling,
appetite regulation and gastrointestinal processes.
GIP
A second incretin pathway investigated for its role in pancreatic and
metabolic signalling.
Glucagon
A metabolic signalling pathway associated with energy expenditure,
hepatic metabolism and lipid handling.
Investigational Research Compound
Retatrutide is an investigational compound undergoing clinical development.
It is not presented by SerenQ as an approved medicine, supplement or
therapeutic product.
This product is supplied strictly as a laboratory research chemical and is
not intended for human or veterinary consumption.
Serialised & QR Verified
Each SerenQ pen is supplied with unique product identification. The pen and
retail packaging carry serial and batch information together with a QR code
for authenticity verification.
Product verification can be accessed through the SerenQ authentication
portal:
auth.seren-q.com
Independent Analysis
The supplied product information states that this batch is undergoing
independent laboratory analysis for purity, identity and potency.
Pre-Filled Format
The SerenQ Retatrutide product is supplied in a sealed, pre-filled pen format.
The same pen platform is used for both the 20mg and 40mg variants, providing a
consistent physical format across the range.
Graduated Window
The pen incorporates a visible graduated scale for laboratory research
handling and volume reference.
Sealed Tips
Four individually sealed 32G 0.23 × 4mm pen tips are supplied with each pen.
Product Identification
Batch, expiry and serial information are provided for product traceability.
Retail Carton
Each pen is supplied in a rigid, serialised retail carton for storage and
transport.
Storage Information
Store refrigerated at 2–8°C. Do not freeze.
Keep inside the outer carton and away from direct light.
The supplied specification describes the solution as clear and colourless.
12/2027 for the supplied sealed stock.
Keep away from children and animals.
What’s Included
Retatrutide Pen
1 × SerenQ Retatrutide pre-filled peptide pen in the selected
20mg or 40mg strength.
Pen Tips
4 × individually sealed 32G 0.23 × 4mm pen tips.
Retail Carton
Serialised and QR-coded product packaging.
For Research Purposes Only
This product is supplied strictly as a laboratory research chemical.
It is not a medicine, supplement or cosmetic and is not intended for human
or veterinary consumption. Retatrutide is an investigational compound and
has no approved clinical indication.
Nothing on this page should be interpreted as medical advice, a treatment
recommendation or a suggestion for use in humans or animals.
By purchasing this product, the purchaser confirms that they are acquiring it
for legitimate laboratory research or analytical purposes and accept
responsibility for lawful handling and use under the regulations applicable
to them.
Additional information
| Select option | 20mg, 40mg |
|---|
Related products
-
Sale!
-
Sale!
-
Sale!
-
Sale!
SerenQ GHRP-6 6mg Peptide Pen
Original price was: £50.00.£35.00Current price is: £35.00.
Reviews
There are no reviews yet.